These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16909107)

  • 21. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase inhibitors induce mitotic slippage.
    Stevens FE; Beamish H; Warrener R; Gabrielli B
    Oncogene; 2008 Feb; 27(10):1345-54. PubMed ID: 17828304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors.
    Inoue T; Nakayama Y; Li Y; Matsumori H; Takahashi H; Kojima H; Wanibuchi H; Katoh M; Oshimura M
    FEBS J; 2014 Jun; 281(11):2623-37. PubMed ID: 24712640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition.
    Suematsu T; Li Y; Kojima H; Nakajima K; Oshimura M; Inoue T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):588-94. PubMed ID: 25285631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirt2 suppresses glioma cell growth through targeting NF-κB-miR-21 axis.
    Li Y; Dai D; Lu Q; Fei M; Li M; Wu X
    Biochem Biophys Res Commun; 2013 Nov; 441(3):661-7. PubMed ID: 24161395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology.
    Harting K; Knöll B
    Eur J Cell Biol; 2010; 89(2-3):262-9. PubMed ID: 20004495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
    Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
    J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.
    Marcotte PA; Richardson PL; Guo J; Barrett LW; Xu N; Gunasekera A; Glaser KB
    Anal Biochem; 2004 Sep; 332(1):90-9. PubMed ID: 15301953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10.
    Bae NS; Swanson MJ; Vassilev A; Howard BH
    J Biochem; 2004 Jun; 135(6):695-700. PubMed ID: 15213244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.
    Trapp J; Jochum A; Meier R; Saunders L; Marshall B; Kunick C; Verdin E; Goekjian P; Sippl W; Jung M
    J Med Chem; 2006 Dec; 49(25):7307-16. PubMed ID: 17149860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.
    Outeiro TF; Kontopoulos E; Altmann SM; Kufareva I; Strathearn KE; Amore AM; Volk CB; Maxwell MM; Rochet JC; McLean PJ; Young AB; Abagyan R; Feany MB; Hyman BT; Kazantsev AG
    Science; 2007 Jul; 317(5837):516-9. PubMed ID: 17588900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer.
    Sze KM; Ching YP; Jin DY; Ng IO
    Cancer Res; 2008 Nov; 68(22):9194-201. PubMed ID: 19010891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene.
    Hiratsuka M; Inoue T; Toda T; Kimura N; Shirayoshi Y; Kamitani H; Watanabe T; Ohama E; Tahimic CG; Kurimasa A; Oshimura M
    Biochem Biophys Res Commun; 2003 Sep; 309(3):558-66. PubMed ID: 12963026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
    Skoge RH; Ziegler M
    J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II induces microtubule reorganization mediated by a deacetylase SIRT2 in endothelial cells.
    Hashimoto-Komatsu A; Hirase T; Asaka M; Node K
    Hypertens Res; 2011 Aug; 34(8):949-56. PubMed ID: 21677656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleocytoplasmic shuttling of soluble tubulin in mammalian cells.
    Akoumianaki T; Kardassis D; Polioudaki H; Georgatos SD; Theodoropoulos PA
    J Cell Sci; 2009 Apr; 122(Pt 8):1111-8. PubMed ID: 19299461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimicrotubule agents can activate different apoptotic pathways].
    Kisurina-Evgen'eva OP; Briantseva SA; Stil' AA; Onishchenko GE
    Biofizika; 2006; 51(5):875-9. PubMed ID: 17131827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuin inhibitors.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different mechanisms of mitotic instability in cancer cell lines.
    Klein A; Zang KD; Steudel WI; Urbschat S
    Int J Oncol; 2006 Dec; 29(6):1389-96. PubMed ID: 17088976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol abolishes resistance to axonal degeneration in slow Wallerian degeneration (WldS) mice: activation of SIRT2, an NAD-dependent tubulin deacetylase.
    Suzuki K; Koike T
    Biochem Biophys Res Commun; 2007 Aug; 359(3):665-71. PubMed ID: 17560549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.